Lv5
1340 积分 2022-09-28 加入
Efficacy and Safety of BL-B01D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Phase II Clinical Trial
4小时前
待确认
Oncology Combination Drug Development Strategies for Project Optimus
2天前
已完结
Endpoint Exposure‐Response Analyses in the Presence of Concurrent Dose Modification During Clinical Trials
1个月前
已完结
Using Quantitative Approaches to Optimize Dosages for New Combinations and Subsequent Indications for Oncology Drugs
1个月前
已完结
Assessment and Reporting of the Clinical Immunogenicity of Therapeutic Proteins and Peptides—Harmonized Terminology and Tactical Recommendations
2个月前
已完结
Prostate cancer
2个月前
已完结
Complexity of Prostate Cancer
2个月前
已完结
Navigating the Challenges of Cyclosporine as an Alternative to Rifampicin as an OATP1B Index Inhibitor
4个月前
已完结
FDA Experience on CAR T Cell Pharmacokinetics/Pharmacodynamics and Model‐Based Assessments
4个月前
已完结
New Approach Methodologies: What Clinical Pharmacologists Should Prepare For
4个月前
已完结
皖公网安备34019202002308
